A Study to Evaluate the Efficacy and Safety of TP-06 for PCED
Public ClinicalTrials.gov record NCT07886268. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Masked, Vehicle Controlled Study to Assess the Efficacy and Safety of TP-06 in Participants With Persistent Corneal Epithelial Defects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Capellion is a Phase 2 trial comparing TP-06 2.0% with Vehicle in up to 32 adults with persistent corneal epithelial defects. Participants will receive treatment for 8 weeks and be followed for 2 additional weeks to assess corneal healing and safety.
Study identification
- NCT ID
- NCT07886268
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 32 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 20, 2026 (Actual)
- Primary completion
- Jul 7, 2028 (Estimated)
- Completion
- Jul 7, 2028 (Estimated)
- Last update posted
- Oct 21, 2026
2026 – 2028
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tarsus Investigative Site | Scottsdale | Arizona | 36301 | Not yet recruiting |
| Tarsus Investigative Site | Tampa | Florida | 33612 | Not yet recruiting |
| Tarsus Investigative Site | Atlanta | Georgia | 30339 | Recruiting |
| Tarsus Investigative Site | Alexandria | Minnesota | 56308 | Recruiting |
| Tarsus Investigative Site | Dover | New Jersey | 07801 | Not yet recruiting |
| Tarsus Investigative Site | Palisades Park | New Jersey | 07650 | Not yet recruiting |
| Tarsus Investigative Site | Babylon | New York | 11702 | Not yet recruiting |
| Tarsus Investigative Site | Mt. Pleasant | South Carolina | 29464 | Not yet recruiting |
| Tarsus Investigative Site | Houston | Texas | 77008 | Recruiting |
| Tarsus Investigative Site | Sugar Land | Texas | 77478 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07886268, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 21, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07886268 live on ClinicalTrials.gov.